Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Clinical and Translational Radiation Oncology|April 18, 2025
Prediction for cardiac and pulmonary toxicity in a multicentric cohort of advanced stage NSCLC patients using sub-regions of the heartAlbrecht Weiß, Steffen Löck, Ting Xu, et al.
Breast Cancer Research : BCR|January 9, 2013
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein responseAnika Nagelkerke, Johan Bussink, Hilda Mujcic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2010
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumoursEsther G C Troost, Dominic A X Schinagl, Johan Bussink, et al.
Head & Neck|January 26, 2007
Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A reviewIlse J Hoogsteen, Henri A M Marres, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2002
Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapyJohan Bussink, Michael R L Stratford, Albert J van der Kogel, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2013
Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancerBianca A W Hoeben, Johan Bussink, Esther G C Troost, et al.
Thoracic Cancer|September 19, 2017
EBUS and EUS guided fine needle aspirations for molecular diagnostic analysis in lung cancerHenricus F M van der Heijden, Monika G Looijen-Salamon, Olga C J Schuurbiers, et al.
Nature Reviews. Clinical Oncology|April 29, 2015
PET in the management of locally advanced and metastatic NSCLCWillem Grootjans, Lioe-Fee de Geus-Oei, Esther G C Troost, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parametersHanneke W M van Laarhoven, Johan Bussink, Jasper Lok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 10, 2017
Preclinical validation of <sup>111</sup>In-girentuximab-F(ab')<sub>2</sub> as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenograftsFokko J Huizing, Bianca A W Hoeben, Gerben Franssen, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Clinical and Translational Radiation Oncology|April 18, 2025
Prediction for cardiac and pulmonary toxicity in a multicentric cohort of advanced stage NSCLC patients using sub-regions of the heartAlbrecht Weiß, Steffen Löck, Ting Xu, et al.
Breast Cancer Research : BCR|January 9, 2013
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein responseAnika Nagelkerke, Johan Bussink, Hilda Mujcic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2010
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumoursEsther G C Troost, Dominic A X Schinagl, Johan Bussink, et al.
Head & Neck|January 26, 2007
Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A reviewIlse J Hoogsteen, Henri A M Marres, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2002
Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapyJohan Bussink, Michael R L Stratford, Albert J van der Kogel, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2013
Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancerBianca A W Hoeben, Johan Bussink, Esther G C Troost, et al.
Thoracic Cancer|September 19, 2017
EBUS and EUS guided fine needle aspirations for molecular diagnostic analysis in lung cancerHenricus F M van der Heijden, Monika G Looijen-Salamon, Olga C J Schuurbiers, et al.
Nature Reviews. Clinical Oncology|April 29, 2015
PET in the management of locally advanced and metastatic NSCLCWillem Grootjans, Lioe-Fee de Geus-Oei, Esther G C Troost, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parametersHanneke W M van Laarhoven, Johan Bussink, Jasper Lok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 10, 2017
Preclinical validation of <sup>111</sup>In-girentuximab-F(ab')<sub>2</sub> as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenograftsFokko J Huizing, Bianca A W Hoeben, Gerben Franssen, et al.
Pageof 22